BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21308881)

  • 1. STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction.
    Rosen MJ; Frey MR; Washington MK; Chaturvedi R; Kuhnhein LA; Matta P; Revetta FL; Wilson KT; Polk DB
    Inflamm Bowel Dis; 2011 Nov; 17(11):2224-34. PubMed ID: 21308881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory cytokines down-regulate the barrier-protective prostasin-matriptase proteolytic cascade early in experimental colitis.
    Buzza MS; Johnson TA; Conway GD; Martin EW; Mukhopadhyay S; Shea-Donohue T; Antalis TM
    J Biol Chem; 2017 Jun; 292(26):10801-10812. PubMed ID: 28490634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines.
    Rosen MJ; Chaturvedi R; Washington MK; Kuhnhein LA; Moore PD; Coggeshall SS; McDonough EM; Weitkamp JH; Singh AB; Coburn LA; Williams CS; Yan F; Van Kaer L; Peebles RS; Wilson KT
    J Immunol; 2013 Feb; 190(4):1849-58. PubMed ID: 23303670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-hematopoietic STAT6 induces epithelial tight junction dysfunction and promotes intestinal inflammation and tumorigenesis.
    Lin Y; Li B; Yang X; Liu T; Shi T; Deng B; Zhang Y; Jia L; Jiang Z; He R
    Mucosal Immunol; 2019 Nov; 12(6):1304-1315. PubMed ID: 31534167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shift from pStat6 to pStat3 predominance is associated with inflammatory bowel disease-associated dysplasia.
    Wick EC; LeBlanc RE; Ortega G; Robinson C; Platz E; Pardoll DM; Iacobuzio-Donahue C; Sears CL
    Inflamm Bowel Dis; 2012 Jul; 18(7):1267-74. PubMed ID: 22021169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
    Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
    Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
    Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
    Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel disease.
    Myers JN; Schäffer MW; Korolkova OY; Williams AD; Gangula PR; M'Koma AE
    Inflamm Bowel Dis; 2014 Sep; 20(9):1530-47. PubMed ID: 25078150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.
    Li Y; Deuring J; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
    Mol Med; 2012 Dec; 18(1):1412-9. PubMed ID: 23154639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of STAT6 signaling pathway blockade on apoptosis of human colon cancer cells].
    Zhang MS; Zhou YF; Xie CH; Zhang WJ; Zhou FX; Qu XJ
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):76-81. PubMed ID: 16620708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis.
    Koukos G; Polytarchou C; Kaplan JL; Morley-Fletcher A; Gras-Miralles B; Kokkotou E; Baril-Dore M; Pothoulakis C; Winter HS; Iliopoulos D
    Gastroenterology; 2013 Oct; 145(4):842-52.e2. PubMed ID: 23856509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D regulates the tight-junction protein expression in active ulcerative colitis.
    Stio M; Retico L; Annese V; Bonanomi AG
    Scand J Gastroenterol; 2016 Oct; 51(10):1193-9. PubMed ID: 27207502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
    Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH
    Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease.
    Zeissig S; Bürgel N; Günzel D; Richter J; Mankertz J; Wahnschaffe U; Kroesen AJ; Zeitz M; Fromm M; Schulzke JD
    Gut; 2007 Jan; 56(1):61-72. PubMed ID: 16822808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway.
    Mandal D; Levine AD
    Inflamm Bowel Dis; 2010 May; 16(5):753-64. PubMed ID: 20014020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of baicalin on signal transduction and activating transcription factor expression in ulcerative colitis patients].
    Yu FY; Huang SG; Zhang HY; Chi HG; Zou Y; Lu RX; Zheng XB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Apr; 35(4):419-24. PubMed ID: 26043563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
    Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
    Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matriptase protects against experimental colitis and promotes intestinal barrier recovery.
    Netzel-Arnett S; Buzza MS; Shea-Donohue T; Désilets A; Leduc R; Fasano A; Bugge TH; Antalis TM
    Inflamm Bowel Dis; 2012 Jul; 18(7):1303-14. PubMed ID: 22081509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.